Life Technologies: Driving Innovation in Biotechnology and Life Sciences

Life Technologies: Driving Innovation in Biotechnology and Life Sciences

Background and Evolution

Life Technologies was founded in 2008 through the merger of Invitrogen Corporation and Applied Biosystems, two prominent companies in the biotechnology industry. The merger brought together complementary expertise and resources, creating a powerhouse with a comprehensive portfolio of products and services for the life sciences market. In 2014, Life Technologies was acquired by Thermo Fisher Scientific, further expanding its reach and capabilities in genetic analysis, cell biology, and other areas of biotechnology.

Diverse Product Portfolio

Life Technologies offered a diverse range of products and solutions tailored to meet the needs of researchers and scientists across various disciplines. Its product portfolio included instruments, reagents, consumables, and software for applications such as DNA sequencing, gene expression analysis, protein purification, cell culture, and more. Whether it was conducting basic research in academia, developing new drugs in the pharmaceutical industry, or diagnosing diseases in clinical settings, provided the tools and technologies needed to advance scientific knowledge and improve human health.

Impact on Scientific Research

Life Technologies had a profound impact on scientific research and discovery, fueling advancements in fields such as genomics, proteomics, stem cell research, and personalized medicine. Its cutting-edge instruments and technologies enabled researchers to study biological processes at the molecular level, unravel the complexities of the human genome, and develop new therapies and treatments for diseases. By democratizing access to high-quality research tools and resources, Life Technologies empowered scientists around the world to push the boundaries of knowledge and make meaningful contributions to society.

Legacy of Innovation

Throughout its history, Life Technologies was known for its culture of innovation and commitment to pushing the boundaries of what’s possible in biotechnology. The company invested heavily in research and development to develop new products, improve existing technologies, and address emerging challenges and opportunities in the life sciences market. From pioneering new methods in DNA sequencing to revolutionizing cell culture techniques, Life Technologies left a lasting legacy of innovation that continues to shape the future of biotechnology and scientific research.


In conclusion, Life Technologies was a trailblazer in the biotechnology industry, driving innovation, and advancing scientific research to improve human health and quality of life. Through its diverse product portfolio, commitment to quality, and culture of innovation, Life Technologies empowered researchers and scientists to unlock the mysteries of life and make groundbreaking discoveries that have the potential to change the world. Though the company is now part of Thermo Fisher Scientific, its legacy of innovation and impact on the life sciences industry will continue to inspire and influence future generations of scientists and researchers.

Author: SARA